A naukri.com initiative
Bioengineer
1w
207
Image Credit: Bioengineer
The length of telomereas a biomarker for early lung cancer detection
- The use of telomere length as a biomarker for early lung cancer detection offers hope for improved survival rates through earlier and more accurate detection, presents a non-invasive, cost-effective, and highly quantifiable biomarker for identifying individuals at heightened risk of lung cancer.
- Telomeres, the protective caps at the ends of chromosomes, play a pivotal role in cellular aging and genomic stability. Their shortening is associated with cellular senescence and disease progression, including cancer.
- The study included 233 high-risk patients undergoing lung cancer diagnosis at two Spanish hospitals, alongside a control group comprising 1,378 healthy individuals or patients with COPD.
- The researchers developed predictive models based on TAV analysis and these models were evaluated using Receiver Operating Characteristic (ROC) curves demonstrating remarkable diagnostic performance.
- Findings revealed that patients in the cancer cohort exhibited significantly shorter telomeres compared to controls, characterized by an overrepresentation of short telomeres and an underrepresentation of long telomeres.
- The results underscore the potential of telomere length analysis to complement existing screening methods, enhancing early detection capabilities, and improving outcomes for patients.
- The relatively small sample size and potential histologic biases warrant caution in interpreting the findings. Additionally, telomere length is influenced by genetic, environmental, and lifestyle factors, necessitating further investigation to refine its clinical application.
- The development of non-invasive biomarkers for cancer detection represents a significant advancement in personalized medicine.
- This study represents a collaborative effort by leading researchers and institutions, supported by funding from Horizon2020, Life Length SL, and various regional and national grants.
- The integration of telomere analysis with LDCT and other biomarkers could revolutionize cancer screening, reducing costs, and improving accessibility for high-risk populations.
Read Full Article
12 Likes
For uninterrupted reading, download the app